Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec;32(12):1103-1114.
doi: 10.1007/s00383-016-3965-3. Epub 2016 Sep 26.

Blockade of the renin-angiotensin system prevents acute and immunologically relevant colitis in murine models

Manabu Okawada  1   2 , Michael W Wilson  3 , Scott D Larsen  3 , Elke Lipka  4 , John Hillfinger  4 , Daniel H Teitelbaum  5
Affiliations

Blockade of the renin-angiotensin system prevents acute and immunologically relevant colitis in murine models

Manabu Okawada et al. Pediatr Surg Int. 2016 Dec.

Abstract

Background: Blockade of the renin-angiotensin system (RAS) has been shown to alleviate inflammatory processes in the gastrointestinal tract. The aim of this study was to determine if blockade of the RAS would be effective in an immunologically relevant colitis model, and to compare outcome with an acute colitis model.

Methods: A losartan analog, CCG-203025 (C23H26ClN3O5S) containing a highly polar sulfonic acid moiety that we expected would allow localized mucosal antagonism with minimal systemic absorption was selected as an angiotensin II type 1a receptor antagonist (AT1aR-A). Two colitis models were studied: (1) Acute colitis was induced in 8- to 10-week-old C57BL/6J mice by 2.5 % dextran sodium sulfate (DSS, in drinking water) for 7 days. (2) IL10-/-colitis Piroxicam (200 ppm) was administered orally in feed to 5-week-old IL-10-/-mice (C57BL/6J background) for 14 days followed by enalaprilat (ACE-I), CCG-203025 or PBS administered transanally for 14 days.

Results: In the DSS model, weight loss and histologic score for CCG-203025 were better than with placebo. In the IL10-/-model, ACE-I suppressed histologic damage better than CCG-203025. Both ACE-I and CCG-203025 reduced pro-inflammatory cytokines and chemokines.

Conclusions: This study demonstrated the therapeutic efficacy of both ACE-I and AT1aR-A for preventing the development of both acute and immunologically relevant colitis.

Keywords: Angiotensin II type Ia receptor; Angiotensin II type Ia receptor antagonist; Angiotensin converting enzyme; Colitis; Dextran sodium sulfate; IL10.

PubMed Disclaimer

References

    1. Gastroenterology. 2002 Nov;123(5):1527-42 - PubMed
    1. J Clin Endocrinol Metab. 2003 Sep;88(9):4496-501 - PubMed
    1. Surgery. 2008 Aug;144(2):259-68 - PubMed
    1. Dig Dis Sci. 2013 Nov;58(11):3165-77 - PubMed
    1. Physiol Rev. 2006 Jul;86(3):747-803 - PubMed

MeSH terms